The Italian pharmaceutical sector, particularly equivalent medicines, has saved the National Health Service approximately €6.25 billion since 2012, enhancing access to affordable care. Undersecretary Marcello Gemmato emphasized the need for supportive policies to foster innovation and investment, while addressing challenges like payback mechanisms that impact pharmaceutical companies. With a production value of €52 billion, Italy stands as a leader in European pharmaceutical innovation, crucial for both economic growth and public health advancements.